Logo image of MLP.CA

MILLENNIAL POTASH CORP (MLP.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:MLP - CA60041F1018 - Common Stock

3 CAD
+0.06 (+2.04%)
Last: 1/20/2026, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, MLP scores 2 out of 10 in our fundamental rating. MLP was compared to 27 industry peers in the Chemicals industry. While MLP has a great health rating, there are worries on its profitability. MLP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year MLP has reported negative net income.
  • In the past year MLP has reported a negative cash flow from operations.
  • MLP had negative earnings in each of the past 5 years.
  • MLP had a negative operating cash flow in each of the past 5 years.
MLP.CA Yearly Net Income VS EBIT VS OCF VS FCFMLP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

  • The Return On Assets of MLP (-18.73%) is worse than 66.67% of its industry peers.
  • MLP has a Return On Equity (-21.54%) which is in line with its industry peers.
Industry RankSector Rank
ROA -18.73%
ROE -21.54%
ROIC N/A
ROA(3y)-40.71%
ROA(5y)-35.79%
ROE(3y)-45.37%
ROE(5y)-97.24%
ROIC(3y)N/A
ROIC(5y)N/A
MLP.CA Yearly ROA, ROE, ROICMLP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

  • MLP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLP.CA Yearly Profit, Operating, Gross MarginsMLP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

8

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, MLP has more shares outstanding
  • The debt/assets ratio for MLP has been reduced compared to a year ago.
MLP.CA Yearly Shares OutstandingMLP.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
MLP.CA Yearly Total Debt VS Total AssetsMLP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • MLP has an Altman-Z score of 68.16. This indicates that MLP is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 68.16, MLP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • MLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 68.16
ROIC/WACCN/A
WACCN/A
MLP.CA Yearly LT Debt VS Equity VS FCFMLP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

2.3 Liquidity

  • A Current Ratio of 9.58 indicates that MLP has no problem at all paying its short term obligations.
  • MLP has a better Current ratio (9.58) than 96.30% of its industry peers.
  • A Quick Ratio of 9.58 indicates that MLP has no problem at all paying its short term obligations.
  • The Quick ratio of MLP (9.58) is better than 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 9.58
Quick Ratio 9.58
MLP.CA Yearly Current Assets VS Current LiabilitesMLP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

0

3. Growth

3.1 Past

  • The earnings per share for MLP have decreased by -1.28% in the last year.
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • MLP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.70% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-6.19%
EPS Next 3Y12.82%
EPS Next 5Y-33.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MLP.CA Yearly EPS VS EstimatesMLP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 -0.05 -0.1 -0.15

0

4. Valuation

4.1 Price/Earnings Ratio

  • MLP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MLP.CA Price Earnings VS Forward Price EarningsMLP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLP.CA Per share dataMLP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

  • MLP's earnings are expected to grow with 12.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.19%
EPS Next 3Y12.82%

0

5. Dividend

5.1 Amount

  • MLP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MILLENNIAL POTASH CORP

TSX-V:MLP (1/20/2026, 7:00:00 PM)

3

+0.06 (+2.04%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners38.98%
Ins Owner ChangeN/A
Market Cap327.87M
Revenue(TTM)N/A
Net Income(TTM)-4.09M
Analysts84.44
Price Target4.9 (63.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)83.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 17.26
P/tB 17.26
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.73%
ROE -21.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.71%
ROA(5y)-35.79%
ROE(3y)-45.37%
ROE(5y)-97.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3563.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.58
Quick Ratio 9.58
Altman-Z 68.16
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)693.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.32%
EPS Next YN/A
EPS Next 2Y-6.19%
EPS Next 3Y12.82%
EPS Next 5Y-33.7%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.84%
OCF growth 3YN/A
OCF growth 5YN/A

MILLENNIAL POTASH CORP / MLP.CA FAQ

What is the fundamental rating for MLP stock?

ChartMill assigns a fundamental rating of 2 / 10 to MLP.CA.


Can you provide the valuation status for MILLENNIAL POTASH CORP?

ChartMill assigns a valuation rating of 0 / 10 to MILLENNIAL POTASH CORP (MLP.CA). This can be considered as Overvalued.


What is the profitability of MLP stock?

MILLENNIAL POTASH CORP (MLP.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for MLP stock?

The financial health rating of MILLENNIAL POTASH CORP (MLP.CA) is 8 / 10.